Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma

✍ Scribed by Thomas M. Barber; Julia Kenkre; Catherine Garnett; Rebecca V. Scott; James V. Byrne; John A. H. Wass

• Book ID: 108704998
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 72 KB
• Volume: 75
• Category: Article
• ISSN: 0300-0664
• DOI: 10.1111/j.1365-2265.2011.04136.x